Investigation of valproic acid-carbamazepine interaction by mixed effect modeling in Chinese epilepsy patients
Mingkang Zhong
Abstract
Mingkang Zhong
Abstract
OBJECTIVE To investigate the valproic acid-earbamazepine interaction in Chinese epilepsy patients. METHODS Nonlinear mixed effects modeling was used to estimate the effects of valproic acid-carbamazepine interaction on their clearance from 722 patients who received valproic acid and/or carbamazepine during their clinical routine care. RESULTS The final model describing VPA clearance was: CL = 0.0072 6 × TBW0.890× (1 + 18.1 DOSE) × 1.36GBZ× 1.22CHILD . The final model describing CBZ clearance was: CL = 1.21× DOSE0.409 ×TBW0.292 × 1.16VPA ×0.845ELDER. Where CL was clearance (L.h-1 ), TBW was total body weight (kg), DOSE was daily dosage (g.d-1. kg~ ) . CBZ = 1 for concomitant administration of CBZ and CBZ = 0 for otherwise; VPA = 1, when VPA dose was higher than 19 mg.kg -1 . CHILD for children less than 6 year and ELDER for people greater than 65 year. CONCLUSION Concomitant adminstration of valproic acid and carbamazepine resulted in 36% increase in valproic acid clearance and 16% increase in carbamazepine clearance when valproic acid daily dose was greater than 19 mg.kg-1 .
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To investigate the valproic acid-earbamazepine interaction in Chinese epilepsy patients. METHODS Nonlinear mixed effects modeling was used to estimate the effects of valproic acid-carbamazepine interaction on their clearance from 722 patients who received valproic acid and/or carbamazepine during their clinical routine care. RESULTS The final model describing VPA clearance was: CL = 0.0072 6 × TBW0.890× (1 + 18.1 DOSE) × 1.36GBZ× 1.22CHILD . The final model describing CBZ clearance was: CL = 1.21× DOSE0.409 ×TBW0.292 × 1.16VPA ×0.845ELDER. Where CL was clearance (L.h-1 ), TBW was total body weight (kg), DOSE was daily dosage (g.d-1. kg~ ) . CBZ = 1 for concomitant administration of CBZ and CBZ = 0 for otherwise; VPA = 1, when VPA dose was higher than 19 mg.kg -1 . CHILD for children less than 6 year and ELDER for people greater than 65 year. CONCLUSION Concomitant adminstration of valproic acid and carbamazepine resulted in 36% increase in valproic acid clearance and 16% increase in carbamazepine clearance when valproic acid daily dose was greater than 19 mg.kg-1 .
Key concepts: Carbamazepine, Valproic Acid, Concomitant, Epilepsy, Anticonvulsant, Pharmacology, Drug interaction, Chemistry